139 related articles for article (PubMed ID: 30902708)
1. Evaluation of size and dose effects of rChe a 3 allergen loaded PLGA nanoparticles on modulation of Th2 immune responses by sublingual immunotherapy in mouse model of rhinitis allergic.
Hajavi J; Hashemi M; Sankian M
Int J Pharm; 2019 May; 563():282-292. PubMed ID: 30902708
[No Abstract] [Full Text] [Related]
2. Allergen-specific sublingual immunotherapy is dose and duration dependent in a murine allergic rhinitis model.
Tofukuji S; Katayama K; Nakano Y; Ishida S; Tsuchida J; Tajiri M; Shimo Y; Tanaka H; Shichijo M
J Allergy Clin Immunol; 2018 Dec; 142(6):1977-1979.e9. PubMed ID: 30102936
[No Abstract] [Full Text] [Related]
3. Enhanced sublingual immunotherapy by TAT-fused recombinant allergen in a murine rhinitis model.
Salari F; Vahedi F; Varasteh AR; Ketabdar H; Chamani J; Sankian M
Int Immunopharmacol; 2017 Jul; 48():118-125. PubMed ID: 28501765
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy with a recombinant hybrid molecule alleviates allergic responses more efficiently than an allergenic cocktail or pollen extract in a model of chenopodium album allergy.
Nouri HR; Sankian M; Afsharzadeh D; Varasteh A
Int Arch Allergy Immunol; 2013; 161(4):325-32. PubMed ID: 23689669
[TBL] [Abstract][Full Text] [Related]
5. Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route?
Nelson HS; Durham SR
J Allergy Clin Immunol Pract; 2017; 5(1):52-57. PubMed ID: 28065341
[No Abstract] [Full Text] [Related]
6. Subcutaneous versus sublingual immunotherapy.
Lin CH; Alandijani S; Lockey RF
Expert Rev Clin Immunol; 2016 Aug; 12(8):801-3. PubMed ID: 27253418
[No Abstract] [Full Text] [Related]
7. [A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy].
Tofukuji S; Ishida S; Katayama K
Nihon Yakurigaku Zasshi; 2017; 150(2):68-71. PubMed ID: 28794300
[No Abstract] [Full Text] [Related]
8. Artemisia annua sublingual immunotherapy in children with seasonal allergic rhinitis.
Tang L; Wang P; Yang X; Zhao J; Pang C; Xiang L; Ge W
Allergy; 2024 May; 79(5):1376-1379. PubMed ID: 38375928
[No Abstract] [Full Text] [Related]
9. Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America.
Moingeon P; Cox L
Expert Rev Clin Immunol; 2016 Jun; 12(6):617-23. PubMed ID: 26813047
[TBL] [Abstract][Full Text] [Related]
10. Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen-specific Th2 response.
Kitzmüller C; Jahn-Schmid B; Kinaciyan T; Bohle B
Allergy; 2019 Aug; 74(8):1579-1581. PubMed ID: 30887520
[No Abstract] [Full Text] [Related]
11. Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.
Baron-Bodo V; Horiot S; Lautrette A; Chabre H; Drucbert AS; Danzé PM; Sénéchal H; Peltre G; Galvain S; Zeldin RK; Horak F; Moingeon P
Clin Exp Allergy; 2013 Dec; 43(12):1362-73. PubMed ID: 24261946
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
Hesse L; Nawijn MC
Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
[TBL] [Abstract][Full Text] [Related]
13. Immune responses modulation by curcumin and allergen encapsulated into PLGA nanoparticles in mice model of rhinitis allergic through sublingual immunotherapy.
Shahgordi S; Sankian M; Yazdani Y; Mashayekhi K; Hasan Ayati S; Sadeghi M; Saeidi M; Hashemi M
Int Immunopharmacol; 2020 Jul; 84():106525. PubMed ID: 32361190
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy for allergic rhinitis: where are we now?
Incorvaia C; Mauro M; Ridolo E
Immunotherapy; 2015; 7(10):1105-10. PubMed ID: 26507464
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of Th2 immune responses by sublingual administration of poly (lactic-co-glycolic) acid (PLGA)-encapsulated allergen in BALB/c mice.
Salari F; Varasteh AR; Vahedi F; Hashemi M; Sankian M
Int Immunopharmacol; 2015 Dec; 29(2):672-678. PubMed ID: 26404189
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
[TBL] [Abstract][Full Text] [Related]
17. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
Mitobe Y; Yokomoto Y; Ohashi-Doi K
Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
[TBL] [Abstract][Full Text] [Related]
18. Immunologic response and safety in birch pollen sublingual versus oral vestibule immunotherapy: a pilot study.
Allam JP; Wuestenberg E; Wolf H; Klimek L; Decot E; Horn A; Schnitker J; Bieber T; Novak N
J Allergy Clin Immunol; 2014 Jun; 133(6):1757-9.e3. PubMed ID: 24794686
[No Abstract] [Full Text] [Related]
19. Sublingual dendritic cells targeting by aptamer: Possible approach for improvement of sublingual immunotherapy efficacy.
Keshavarz Shahbaz S; Varasteh AR; Koushki K; Ayati SH; Mashayekhi K; Sadeghi M; Moghadam M; Sankian M
Int Immunopharmacol; 2020 Aug; 85():106603. PubMed ID: 32485357
[TBL] [Abstract][Full Text] [Related]
20. Sialylated Fetuin-A as a candidate predictive biomarker for successful grass pollen allergen immunotherapy.
Caillot N; Bouley J; Jain K; Mariano S; Luce S; Horiot S; Airouche S; Beuraud C; Beauvallet C; Devillier P; Chollet-Martin S; Kellenberger C; Mascarell L; Chabre H; Batard T; Nony E; Lombardi V; Baron-Bodo V; Moingeon P
J Allergy Clin Immunol; 2017 Sep; 140(3):759-770.e13. PubMed ID: 27965111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
